Abl Bio, Inc.
Clinical trials sponsored by Abl Bio, Inc., explained in plain language.
-
New antibody duo targets advanced cancers in early trial
Disease control Recruiting nowThis study tests a new drug called ABL103, given with the immunotherapy pembrolizumab and sometimes a chemotherapy (taxane), for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and can shrink or …
Phase: PHASE1, PHASE2 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called ABL103 in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest dose and check for side effects. About 96 participants will receive the drug to see if it can hel…
Phase: PHASE1 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC